The trials are randomized, double-blinded, sham-controlled studies to determine the safety and effectiveness of the company’s non-thermal pulsed radiofrequency technology to reduce narcotic use, decrease pain and increase function for patients. The trials are expected to yield results sometime in 2012.
The trial for the rotator cuff repair procedure will enroll 102 patients and follow them for six weeks. The knee trial will enroll 100 patients and follow them for four weeks.
Related Articles on Orthopedic Devices:
VertiFlex Completes Superion Interspinous Trial Enrollment
Orthopedic Device Company Stock Prices Continue to Fall
Stryker Closes Two Gaymar Industries Locations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.